Real-World Experience with 177 Lu-PSMA-617 Radioligand Therapy After Food and Drug Administration Approval.
- Resource Type
- Article
- Source
- Journal of Nuclear Medicine; May2024, Vol. 65 Issue 5, p735-739, 5p
- Subject
- Language
- ISSN
- 01615505